中国生化药物杂志
中國生化藥物雜誌
중국생화약물잡지
CHINESE JOURNAL OF BIOCHEMICAL PHARMACEUTICS
2014年
2期
110-111
,共2页
丹参川芎嗪注射液%缺血性脑卒中%临床研究
丹參川芎嗪註射液%缺血性腦卒中%臨床研究
단삼천궁진주사액%결혈성뇌졸중%림상연구
salviae miltiorrhizae and ligustrazine hydrochloride injection%ischemic stroke%clinical study
目的:观察丹参川芎嗪注射液在辅助辨治缺血性脑卒中过程中的作用和临床效果。方法选取142例缺血性脑卒中患者,按照随机数字表分为试验组和对照组。对照组(n=71)采用常规治疗;试验组(n=71)在常规治疗的基础上加用丹参川芎嗪注射液进行辅助辨治。分别观察治疗前后2组患者的血液流变学变化、神经功能改善情况和治疗效果并进行统计学分析。结果治疗后,对照组患者血浆黏度1.91±0.35,红细胞压积(49.58±1.04)%;试验组患者血浆黏度1.17±0.28,红细胞压积(38.97±1.31)%,2组差异显著(P<0.05)。治疗前对照组神经功能评分为22.49±1.21,试验组患者治疗前评分为23.18±1.74,2组差别不大。治疗后,对照组评分10.58±0.94,试验组为4.62±2.05,2组差异显著(P<0.05)。对照组治疗后总有效率80.3%;试验组治疗后总有效率88.7%,2组差异显著(P<0.05)。结论丹参川芎嗪注射液辅助辨治缺血性脑卒中疗效确切,患者症状得到有效缓解。
目的:觀察丹參川芎嗪註射液在輔助辨治缺血性腦卒中過程中的作用和臨床效果。方法選取142例缺血性腦卒中患者,按照隨機數字錶分為試驗組和對照組。對照組(n=71)採用常規治療;試驗組(n=71)在常規治療的基礎上加用丹參川芎嗪註射液進行輔助辨治。分彆觀察治療前後2組患者的血液流變學變化、神經功能改善情況和治療效果併進行統計學分析。結果治療後,對照組患者血漿黏度1.91±0.35,紅細胞壓積(49.58±1.04)%;試驗組患者血漿黏度1.17±0.28,紅細胞壓積(38.97±1.31)%,2組差異顯著(P<0.05)。治療前對照組神經功能評分為22.49±1.21,試驗組患者治療前評分為23.18±1.74,2組差彆不大。治療後,對照組評分10.58±0.94,試驗組為4.62±2.05,2組差異顯著(P<0.05)。對照組治療後總有效率80.3%;試驗組治療後總有效率88.7%,2組差異顯著(P<0.05)。結論丹參川芎嗪註射液輔助辨治缺血性腦卒中療效確切,患者癥狀得到有效緩解。
목적:관찰단삼천궁진주사액재보조변치결혈성뇌졸중과정중적작용화림상효과。방법선취142례결혈성뇌졸중환자,안조수궤수자표분위시험조화대조조。대조조(n=71)채용상규치료;시험조(n=71)재상규치료적기출상가용단삼천궁진주사액진행보조변치。분별관찰치료전후2조환자적혈액류변학변화、신경공능개선정황화치료효과병진행통계학분석。결과치료후,대조조환자혈장점도1.91±0.35,홍세포압적(49.58±1.04)%;시험조환자혈장점도1.17±0.28,홍세포압적(38.97±1.31)%,2조차이현저(P<0.05)。치료전대조조신경공능평분위22.49±1.21,시험조환자치료전평분위23.18±1.74,2조차별불대。치료후,대조조평분10.58±0.94,시험조위4.62±2.05,2조차이현저(P<0.05)。대조조치료후총유효솔80.3%;시험조치료후총유효솔88.7%,2조차이현저(P<0.05)。결론단삼천궁진주사액보조변치결혈성뇌졸중료효학절,환자증상득도유효완해。
Objective To observe the effect of Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection in inauxiliary treatment of ischemic stroke and its clinical efficacy. Methods 142 cases of patients with ischemic stroke, were randomly divided into experimental group and control group. Control group(n=71) were treated with conventional therapy. Test group(n=71) were treated with Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection on the basis of conventional therapy. Hemorheological changes, nerve function improvement and treatment efifcacy in two groups before and after treatment were observed and analyzed. Results After treatment, the plasma viscosity and hematocrit in control group were 1.91±0.35, (49.58±1.04)%; while experimental group were 1.17±0.28, (38.97±1.31)%, the differences between two groups were signiifcant(P<0.05). Before treatment, the neurological function score in control group was 22.49±1.21, while experimental group was 23.18±1.74, there was no signiifcant difference between two groups. After treatment, the neurological function score in control group was 10.58±0.94, while experimental group was 4.62±2.05, the difference was signiifcant(P<0.05). The total effective rate was 80.3%in control group ,while 88.7% in experimental group, the difference was signiifcant(P<0.05). Conclusion The clinical efifcacy of Salviae Miltiorrhizae and Ligustrazine Hydrochloride Injection in auxiliary treatment of ischemic stroke was accurate, and it can alleviate the symptom of patients.